Alfonso Valencia

2021

• Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies

  Transboundary and Emerging Diseases

  J. Vergara‐Alert, J. Rodon, J. Carrillo, N. Te, N. Izquierdo‐Useros, M. Luisa Rodr de la Concepción, C. Ávila‐Nieto, V. Guallar, A. Valencia, G. Cantero, J. Blanco, B. Clotet, A. Bensaid, and J. Segalés
• Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean

  The Lancet Oncology

  G. Werutsky, C. H. Barrios, A. F. Cardona, A. Albergaria, A. Valencia, C. G. Ferreira, C. Rolfo, E. de Azambuja, G. A. Rabinovich, G. Sposetti, O. Arrieta, R. Dienstmann, T. F. Rebelatto, V. Denninghoff, V. Aran, and E. Cazap
• Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs

  Computational and Structural Biotechnology Journal

  C. Pontes, V. Ruiz-Serra, R. Lepore, and A. Valencia
• BioFVM-X: An MPI+OpenMP 3-D Simulator for Biological Systems

  G. Saxena, M. Ponce-de-Leon, A. Montagud, D. Vicente Dorca, and A. Valencia
• STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells

  Nucleic Acids Research

  L. Richart, E. Lapi, V. Pancaldi, M. Cuenca-Ardura, E. Carrillo-d Pau, M. Madrid-Mencía, H. Neyret-Kahn, F. Radvanyi, J. Antonio Rodríguez, Y. Cuartero, F. Serra, F. Le Dily, A. Valencia, M. A. Marti-Renom, and F. X. Real
• Computational analysis of sense-antisense chimeric transcripts reveals their potential regulatory features and the landscape of expression in human cells

  NAR Genomics and Bioinformatics

  S. Mukherjee, R. Detroja, D. Balamurali, E. Matveishina, Y. A. Medvedeva, A. Valencia, A. Gorohovski, and M. Frenkel-Morgenstern
• Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer

  Cancers

  J. Forés-Martos, C. Boullosa, D. Rodrigo-Domínguez, J. Sánchez-Valle, B. Suay-García, J. Climent, A. Falcó, A. Valencia, J. Anton Puig-Butillé, S. Puig, and R. Tabarés-Seisdedos
• Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster

  Emerging Microbes & Infections

  M. Brustolin, J. Rodon, M. Luisa Rodr de la Concepción, C. Ávila-Nieto, G. Cantero, M. Pérez, N. Te, M. Noguera-Julian, V. Guallar, A. Valencia, N. Roca, N. Izquierdo-Useros, J. Blanco, B. Clotet, A. Bensaid, J. Carrillo, J. Vergara-Alert, and J. Segalés
• Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies

  Transboundary and Emerging Diseases

  J. Vergara‐Alert, J. Rodon, J. Carrillo, N. Te, N. Izquierdo‐Useros, M. Luisa Rodr de la Concepción, C. Ávila‐Nieto, V. Guallar, A. Valencia, G. Cantero, J. Blanco, B. Clotet, A. Bensaid, and J. Segalés
• Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug

  Frontiers in Pharmacology

  J. Rodon, J. Muñoz-Basagoiti, D. Perez-Zsolt, M. Noguera-Julian, R. Paredes, L. Mateu, C. Quiñones, C. Perez, I. Erkizia, I. Blanco, A. Valencia, V. Guallar, J. Carrillo, J. Blanco, J. Segalés, B. Clotet, J. Vergara-Alert, and N. Izquierdo-Useros